REVISTA DE PEDIATRÍA

 

DENGUE HEMORRÁGICO EMERGENCIA

PEDIÁTRICA EN EL HUILA

 

 Haga su consulta por tema
 

 

BIBLIOGRAFÍA

 

1. Gubler DJ. Dengue and dengue haemorragic fever. Clin Microbiol Rev 1998; 11: 480-96.

 

2. Anonymous. Dengue in the americas: Time to talk. Lancet 1997; 350: 455.

 

3. Secretaría de Salud Departamental del Huila. Sección epidemiología. 1993.

 

4. Martínez E. Dengue hemorrágico en niños. Ministerio de Salud, Santafé de Bogotá 1990.

 

5. Salgado Doris. Dengue hemorrágico en el Huila. Publicaciones periódicas de Nestlé 1994 Nº.124. Colombia.

 

6. Halstead SB. Dengue and dengue hemorragic fever. In Feigin C. Pediatric Infectious Disease. Fourth edition. Saunders. Philadelphia 1984, 1993 y1998.

 

7. Gubler DJ. Dengue and dengue hemorragic fever. CAB International, London. UK. 1997; 1-22, 115-32, 367-78.

 

8. Nouri G, Guzman MG, Valdes L. Reemergence of dengue in Cuba. Emerg Infec Dis. 1998; 4: 89-92.

 

9. Halstead SB. Pathogenesis of dengue: Challenges to molecular Biology Science 1988; 239: 476-81.

 

10. Guzman M, Kouri G. Advances in dengue diagnosis. Clin Diagn Lab Immunol 1996; 3: 621-7.

 

11. Vance JD, Duane J, Gluber J. Epidemic dengue in Brazil. 1986. Evolucion of a clinically based dengue surveillance system. Am J Epidemiology. 1990; 131: 693-701.

 

12. Publicación OMS "Fiebre hemorrágica dengue". Diagnóstico, tratamiento y prevención. Ginebra, 1986.

 

13. Mautner I, Robinson M, Kuhnle U. Dengue virus infection. Epidemiology, pathogenesis, clinical presentation, diagnosis and prevention. J Pediatrics, 1998; 131: 516-24.

 

14. Halstead SB. The pathogenesis of dengue. Am J Epidemiol 1981; 14: 632-47.

 

15. Henchal EA, Narupiti S, Feighny R, Pabmanabhan R, Vakharia V. Detection of dengue virus RNA using nucleid acid hibridization. J Virol Methods. 1987; 15: 187-200.

 

16. Deubel V, Laille M, Hugnot JP, Chungue E, Guesdon JL, Drouet MT y cols. Identification of dengue sequences by genomic amplification: Rapid diagnosis of dengue virus serotypes in peripheral blood. J Virol Methods 1990; 30: 41-54.

 

17. Fraser HS, Wilson WA, Rose E, Thomas EJ, Sissonns JG. Dengue fever in Jamaica with shock and hipocomplementaemia, hemorragic, Visceral and neurological complication. West Indian Med J 1978; 7: 106-16.

 

18. Kho LK, Sumarmo WH, Jahhja EC, Gubler DJ. Dengue hemorragic fever accompanied by encefalopathy in Jakarta. Southeast Asian J Trop Med Public Healt. 1981; 12: 83-6.

 

 

19. George R, Liam CD, Chua CT, Lam SK, Pang T, Geethan R, Fo LS. Unusual clinical manifestations of dengue virus infection. Southeast Asian J Trop Med Public Health. 1989; 19: 585-90.

 

20. Manaloto CR, Hayer CG. Isolation of dengue viruses from hospitalized patients in the Philippines, 1983-1986. Southeast Asian J Trop Med Public Health. 1989; 20: 541-7.

 

21. Nimmannitya S, Halsted S et al. Dengue and chincungunya virus infection man in Thailand. 1962-1964 Am J Trop Med.18: 954-71, 1799-969.

 

22. Sangkawibha N. Srojanasuphot. S et al. Risk factors in dengue shock sindrome, in Thailand. Am J Epidemiol. 1984; 120: 653-69.

 

23. Halstead SB, Nimmannityas S, hemorragic fever in Thailand, newer knowledge regarding, etiology. Japan I Med. 1967; 20: 96-103.

 

24. Kliks SC, Nimmannityas S. Evidence that maternal dengue antibodies are important in the development of dengue hemorragic fever in infants. Am J Trop Med Hyg. 1988; 38: 411-9.

 

25. Halstead SB. Larsen K, Kliks S. Et al: comparison of P388D. Mouse macrophage cell line and human monocyte for assay of dengue 2 infection enhancing antibodies. Am J Trop Med . 1483; Hyg 32: 157-63.

 

26. Halstead SB. Dengue: Hematologic aspects. Semin hematolog. 1982; 19: 16-131.

 

27. Ramos C, García H, Villaseca J.M, Fiebre hemorrágica y síndrome de shock por dengue. Salud Pública 1993; Mex. 39-55.

 

28. Bethell DB, Flobbe K, Cao XT. Pathophysiologic and prognostic role of cytokines in haemorragic dengue. J. Infect Dis. 1998; 177: 778-82.

 

29. Vaughn DW, Green S, Kalayanarooj S. Dengue haemorragic fever. J Infec Dis . 1997; 176: 322-30.

 

30. Beutler B, Cerami A.The biology of cachectin/TNF-A primary mediator of the host response. Ann Rev Immunol. 1989; 7: 625-55.

 

31. Jaatela M. Biologic activities and mechanisms of action of tumor necrosis factor - cachectin. Lab Invest. 1991; 64: 724-42.

 

32. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. New Eng J Med. 1996; 334: 1717-25.

 

33. Parrillo JE. The cardiovascular pathophysiology of sepsis. Ann Rev Med. 1989; 40: 469-85.

 

34. Dinarello C. Role of interleukin 1 and tumor necrosis factor in systemic responses to infection and Inflammation. In Gallin JI, Goldstein IM Snyderman R Eds. Raven Press. New York. 1992; 211-32.

 

35. Dinarello C. Biologic basis for Interleukin 1 and disease. Blood. 1996; 87: 2095-147.